ENTITY
Mesoblast Ltd

Mesoblast Ltd (MSB AU)

72
Analysis
Health CareAustralia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
bullishAllkem Ltd
28 May 2021 05:50

ASX200 Index Rebalance Preview: Gold Miners Shining

We see 3 potential changes to the ASX200 in the June review. All inclusions/exclusions have over 3 days of ADV to trade from passive funds. Short...

Logo
472 Views
Share
bullishCodan
01 Mar 2021 06:18

ASX200 Index Rebalance Preview: Three Potential Changes & Some Close Names

We see three potential changes to the ASX200 in the March review while there are another two close adds/deletes. High short interest on the...

Logo
560 Views
Share
12 Jun 2020 11:25

ASX200 Index Review - A Handful of Changes

S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...

Logo
621 Views
Share
05 Sep 2019 14:55

Australia Short Interest - August in Review

Of the 134 companies that reported annual results in August, 65% missed their targets on the top line and just over half reported a rise in profits...

Logo
526 Views
Share
bullishMesoblast Ltd
13 Jul 2018 10:59

Raising FVE for Mesoblast After Adjusting for AUD as We Await 180 Day Survival Data in AGvHD

We are raising our fair value estimate for no-moat Mesoblast Ltd (MSB AU) to AUD 2.90 from AUD 2.60 previously, after adjusting for the recent...

Share
x